Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Impact of Precision Medicine and Genomics on Patient Treatment
Posted on August 26th, 2016 by Dr. Makarand Jawadekar, Ph.D in Chemistry
In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.
The 10 most talked-about journal articles about Alzheimer’s Disease
Posted on August 2nd, 2016 by Betsy Davis in Pharma R&D
The Alzheimer’s Association International Conference just wrapped up in Toronto, Canada (Patrick May was there and will be writing all about it). In honor of the conference, here is a list of Alzheimer’s-related journal articles that were most-talked about in the last month in social media, blogs, and news coverage. (more…)
A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2
Posted on July 18th, 2016 by Christy J. Wilson in Pharma R&D
As referenced in my last post, the Drug Information Association (DIA), held its annual conference in Philadelphia at the end of June with this year’s theme being “A Gathering of Global Perspectives.” In follow-up to that post, I want to share with you what I gleaned from two additional noteworthy sessions. (more…)
Advancing the Development and Clinical Use of Biomarkers
Posted on June 21st, 2016 by Christy J. Wilson in Pharma R&D
Biomarker-based patient selection for clinical trials, a hallmark of precision medicine, is gaining traction. On Monday June 6, a team of researchers reported at the American Society of Clinical Oncology annual meeting and in an online paper in JAMA Oncology that biomarker selection results in better outcomes in Phase l trials. (more…)
